News about "Lupin Limited"

Lupin Launches Diabetes Drug Combination in the US

Lupin launches dapagliflozin and metformin extended-release tablets in the US, offering a bioequivalent and cost-effective alternative for type 2 diabetes management.

Lupin Limited | 22/04/2026 | By News Bureau

Lupin Limited Receives USFDA EIR for Goa Manufacturing Facility

Lupin Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its manufacturing facility in Goa. The report follows a recent inspection of the site and marks the formal closure of the regulatory review process.

Lupin Limited | 01/03/2026 | By Darshana |  121

Lupin Limited partners with Spektus Pharma to commercialize DeslaFlex in Canada

Lupin Limited has signed a licence and supply agreement with Spektus Pharma to commercialize DeslaFlex, a novel antidepressant, in Canada.

Lupin Limited | 16/02/2026 | By Darshana |  120

Lupin Launches Dasatinib Tablets in USA Following FDA Approval

Lupin Limited has announced the launch of dasatinib tablets in multiple strengths in the United States following approval of its Abbreviated New Drug Application from the USA Food and Drug Administration.

Lupin Limited | 03/02/2026 | By Darshana |  182

Lupin acquires brands ONDERO, ONDERO MET brand from Boehringer Ingelheim

Lupin acquires brands ONDERO, ONDERO MET brand from Boehringer Ingelheim

Lupin Limited | 21/08/2023 | By Sudeep Soparkar |  768

Lupins Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations

Lupin’s Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations

Lupin Limited | 14/08/2023 | By Sudeep Soparkar |  896

Lupin receives tentative approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets

Lupin receives tentative approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets

Lupin Limited | 24/07/2023 | By Sudeep Soparkar |  656

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Lupin Limited | 18/07/2023 | By Sudeep Soparkar |  646

Lupin receives approval from U.S. FDA for Diazepam Rectal Gel

Global pharma major Lupin Limited (Lupin) today announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has received approval from the United States Food and Drug Administration (U.S. FDA)

Lupin Limited | 02/06/2023 | By Sudeep Soparkar |  791